Cefditoren

Cefditoren is a broad spectrum, third-generation cephalosporin antibiotic with (Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. Generally administered as its orally absorbed pivaloyloxymethyl ester prodrug, it is used to treat mild to moderate infections caused by susceptible strains of microorganisms in acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, pharyngitis/tonsillitis, and uncomplicated skin and skin-structure infections. Among its listed roles, it functions as a antibacterial drug. It is a cephalosporin and a carboxylic acid. It is grouped under the following drug class(es): Cephalosporins. Its therapeutic use is listed as anti-infectives and antibiotics. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include cefditorene, Cefditoreno, 81QS09V3YW and CHEBI:59343. Its PubChem CID is 9870843.

CAS No 104145-95-1
Molecular Formula C19H18N6O5S3
Molecular Weight 506.6 g/mol
Synonyms (6R,7R)-7-{[(Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(Z)-2-(4-methylthiazol-5-yl)vinyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Frequently Asked Questions